-
D655748-1mlDGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1:antiobesity agents.IC50 value:Target: DGAT-1Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. Findings
-
D651790-100mgDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D651790-10mgDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D651790-1mgDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D651790-50mgDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D651790-5mgDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D656828-1mlDGAT1-IN-1 is a potent DGAT1 inhibitor with IC50 of <: 10 nM(cell lysate from Hep3B cells overexpressing human DGAT1).IC50 value: <: 10 nMTarget: DGAT1 inhibitorImidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol
-
D647241-100mgDGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1 , with IC 50 s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1 . DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndromeIn
-
D647241-10mgDGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1 , with IC 50 s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1 . DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndromeIn
-
D647241-50mgDGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1 , with IC 50 s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1 . DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndromeIn
-
D647241-5mgDGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1 , with IC 50 s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1 . DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndromeIn
-
D654941-1mlDGAT1-IN-3 is a potent, selective and orally bioavailable inhibitor of DGAT-1 , with IC 50 s of 38 nM for human DGAT-1 and 120 nM for rat DGAT-1 . DGAT1-IN-3 could be used to research of obesity, dyslipidemia, and metabolic syndromeIn